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Individuals with cerebral palsy (CP) have increased risk for early development of osteoporosis; 
however, little is known about the epidemiology of osteoporosis for adults with CP, which is 
vital to inform clinical practice for osteoporosis prevention, treatment, and management. The 
purpose of this cross-sectional study was to determine sex-stratified prevalence of osteoporosis 
among adults with CP, as compared to adults without CP. Data from 2016 were extracted from 
Optum Clinformatics® Data Mart (private insurance) and a random 20% sample from the fee-
for-service Medicare (public insurance). Diagnostic codes were used to identify CP and 
osteoporosis diagnoses. Sex-stratified prevalence of osteoporosis was compared between adults 
with and without CP for the following age groups: 18-30, 31-40, 41-50, 51-60, 61-70, and >70 
years of age. The overall prevalence of osteoporosis was 4.8% for adults without CP (n=8.7 
million), 8.4% for privately insured adults with CP (n=7,348), and 14.3% for publicly insured 
adults with CP (n=21,907). Women and men with CP had higher prevalence of osteoporosis 
compared to women and men without CP for all age groups. Finally, publicly insured women 
and men with CP had higher prevalence of osteoporosis compared to privately insured women 
and men with CP for all age groups, except for the similar prevalence among the 18-30 year age 
group. These findings suggest that osteoporosis is more prevalent among adults with CP 
compared to adults without CP. Study findings highlight the need for earlier screening and 
preventive medical services for osteoporosis management among adults with CP.  
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In the U.S., an estimated 10.3% of adults over the age of 50 years have osteoporosis.(1) 
Osteoporosis is a high-burden medical condition characterized by low bone mass or poor bone 
quality. A major consequence of osteoporosis is increased risk for fragility fracture. Among 
older adults, fracture care represents a significant economic burden, accounting for 68% of the 
total cost of osteoporosis treatment.(2,3) Fracture is also a major cause of functional limitations,(4) 
morbidity (e.g., noncommunicable diseases),(5) poor quality of life,(6) and early mortality.(4,7,8) 
Microsimulation forecasting models have estimated that improving osteoporosis identification by 
20% among elderly women (an at-risk population for osteoporosis) could prevent 2.6 million 
fractures from 2018 to 2040 (assuming adequate treatment would be applied), which could lead 
to reducing cumulative osteoporosis-related costs of nearly $42 billion over the same time 
period.(9) While osteoporosis and osteoporotic fractures are more commonly studied among post-
menopausal women and adults over the age of 65 years, other segments of the population are 
vulnerable to fracture and warrant attention.(10) For example, risk for developing osteoporosis is 
higher for populations that have pediatric-onset physical disabilities, such as cerebral palsy 
(CP).(11,12)  
CP is the most common physical disability in children affecting approximately 3.3 per 
1000 children in the U.S.(13-15) CP follows from an insult or malformation of the developing 
central nervous system near the time of birth,(16) leading to chronic and altered muscle tone,(17) 
muscle contractures,(18) dystonia,(19) and low levels of physical activity.(20) During development, 
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low mechanical loading precipitates skeletal adaptation among children with CP, including an 
underdeveloped trabecular bone microarchitecture,(21) thin cortices,(22) and low bone strength.(20) 
Despite knowledge of skeletal pathology and low peak bone mass attainment throughout growth 
and development, very little is known about the pathogenesis of skeletal fragility and the clinical 
care needed to prevent and manage osteoporosis and osteoporotic fractures among adults with 
CP. 
 The prevalence of osteoporosis in adults with CP has been recently reported to be 8.0%, 
10.3%, 14.5%, and 25.9% for adults aged 18-30, 31-40, 41-50, and >50 years, respectively.(23) 
However, inferences are limited as these data came from a single medical center in southeast 
Michigan, were not stratified by sex, and did not have controls to determine the extent of the 
osteoporosis-related disparity. Moreover, risk of fracture is more than two times higher among 
privately insured young and middle-aged adults (18-64 years) with CP compared to adults 
without CP.(24) Taken together, there is a critical need to characterize the epidemiology of 
osteoporosis among individuals with CP throughout the adult lifespan, which can assist clinical 
care and public health surveillance for this underserved population. For example, knowing this 
information can help to identify the age at which osteoporosis is occurring, which can assist 
treatment strategies for the prevention of osteoporosis and management of osteoporosis and its 
sequela (e.g., fracture) for this vulnerable population. Accordingly, the purpose of this study was 
to determine sex-stratified prevalence of osteoporosis among adults with CP, as compared to 
adults without CP, using nationwide private and public administrative claims data. We 
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hypothesized that women and men with CP would have higher prevalence of osteoporosis 
compared to women and men without CP across the adult lifespan.  
 
Materials and Methods 
Data sources 
 Data for this study were extracted from private and public administrative claims data 
from the year 2016. Optum Clinformatics® Data Mart Database (OptumInsightTM, Eden Prairie, 
MN, USA) provided de-identified information for privately insured beneficiaries. A random 20% 
sample of the Medicare fee-for-service database from the Centers for Medicare & Medicaid 
Services provided de-identified information for publicly insured beneficiaries. Since data are de-
identified, the local IRB approved this study as non-regulated.  
 
Sample selection 
Beneficiaries who were 18 years of age or older, had 12 full months of continuous 
enrollment in at least one health plan, and had at least one medical service utilization in 2016 
were initially included for analysis. We excluded Medicare beneficiaries covered by HMO plans 
because of incomplete claims, which could bias prevalence estimates. Beneficiaries who had 
unknown or missing data for sex were excluded (n=991 from Optum, <0.01% of total sample).  
International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) 
codes were used to identify all medical conditions, which are used for reimbursement purposes. 
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ICD-10 codes are entered into the billing system by healthcare providers. Information regarding 
how diagnoses were made are not available in administrative claims data. CP was identified by at 
least one medical claim using the G80 family of ICD-10 codes (7 codes), covering all diagnostic 
subtypes of CP (e.g., spastic quadriplegic, tetraplegic). Data regarding severity of CP using 
common clinical measures (e.g., gross motor function classification system) are not available in 
administrative claims. Further, more than 70% of the cohort had “other” or “unspecified” CP, 
thus not allowing us to stratify or account for the clinical subtypes of CP (e.g., 
spasticity/athetoid, hemiplegic) in the current study. However, data from Optum likely reflects 
the higher-functioning segment of the CP population (e.g., mild to moderate forms of CP).(24) 
Therefore, insurance coverage will be used to stratify results. Using a single medical claim to 
identify a pediatric-onset disability using administrative claims data has shown approximately 
80% positive predictive value and 99% sensitivity.(25)  
 Beneficiaries without any medical claims for CP represented the group without CP (i.e., 
control subjects), and were extracted from the Optum data source only. Using Optum to extract 
claims for the group without CP was performed to enhance the representativeness of our sample 
of adults without CP, as enrollment criteria for Medicare among individuals under 65 years of 
age requires permanent disability, such as end-stage renal disease.  
 
Osteoporosis 
This article is protected by copyright. All rights reserved.
9 
 
 A medical diagnosis of osteoporosis was identified by using at least one claim (ICD-10 
codes) for (1) osteoporosis without current pathological fracture (M81 family; 3 codes) or (2) 
osteoporosis with current pathological fracture (M80 family; 276 codes). Validation of 
identifying beneficiaries with osteoporosis from administrative claims data using diagnostic 
codes has been reported. Leslie et al.(26) found that a case definition of at least one claim for 
osteoporosis had approximately 70% sensitivity, 95% specificity, and 92% positive predictive 
value for a one-year period, which was better or similar to other case definitions developed by 
experts in the field.    
 
Sociodemographic and socioeconomic variables 
Sociodemographic and socioeconomic variables that were available and reported in the 
same manner from both data sources included age and sex. Other confounding variables were not 
considered for covariate adjustment to limit bias for reasons such as they had not been reported 
in both data sources (e.g., education level), they had not been reported in the same manner (e.g., 
race), or they had missing data on over 20% of the cohort (e.g., income). 
 
Statistical analysis 
 Descriptive characteristics were summarized using mean (standard deviation [SD]) for 
continuous variables and percentage for categorical variables. Group differences (i.e., privately 
insured adults with CP, publicly insured adults with CP, adults without CP) in descriptive 
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characteristics and unadjusted prevalence of osteoporosis were examined using independent t-
tests or Chi-square tests.  
We performed direct age-standardization(27) for osteoporosis for each group. The 2016 
U.S. adult population was used as a standard population. The U.S. Census Bureau released a 
table on age (5-year age brackets) and sex composition in the U.S. for 2016.(28) In order to make 
use of the population table in 5-year age groups, it was assumed that age was evenly distributed 
within the 15-19 year age bracket. Therefore, since 6.8% of U.S. males were 15-19 years old, it 
was assumed that 2.72% males were 18-19 years old (6.8% x (2/5)). A similar approach was 
performed for females.  
To examine the prevalence of osteoporosis across age and sex, age was stratified into the 
following categories to represent different stages of the adult lifespan, as previously described 
for adults with CP(23,29) and the general population:(2) 18-30, 31-40, 41-50, 51-60, 61-70, and >70 
years of age.  
 P≤0.005 (two-tailed) was used to determine statistical significance for this large sample, 
as recommended by a coalition of methodologists to detect new discoveries.(30,31) All analyses 
were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).     
 
Results 
 The final sample consisted of 8,732,455 privately insured adults without CP, 7,348 
privately insured adults with CP, and 21,907 publicly insured adults with CP. Descriptive 
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characteristics for study participants are presented in Table 1. Both privately and publicly 
insured adults with CP had younger age and lower proportion of females compared to adults 
without CP. The unadjusted prevalence of osteoporosis was significantly higher for publicly 
insured adults with CP (14.3%) compared to privately insured adults with CP (8.4%; p<0.005) 
and adults without CP (4.8%; p<0.005). The unadjusted prevalence of osteoporosis was 
significantly higher for privately insured adults with CP compared to adults without CP 
(p<0.005). For women, the age-standardized prevalence of osteoporosis was 4.9% for individuals 
without CP, 10.4% for privately insured individuals with CP, and 16.5% publicly insured 
individuals with CP. For men, it was 0.6%, 4.7%, and 9.0%, respectively.  
 Unadjusted prevalence of osteoporosis across age and sex strata is presented in Figure 1. 
There was an increasing trend of osteoporosis for adults without CP and for the combined 
sample of adults with CP. Women and men with CP had higher prevalence of osteoporosis 
compared to women and men without CP for all age groups. For women without CP, prevalence 
of osteoporosis was 0.1% for 18-30 years and 18.6% for >70 years. For women with CP, 
prevalence of osteoporosis was 3.6% for 18-30 years and 33.1% for >70 years. For men without 
CP, prevalence of osteoporosis was 0.1% for 18-30 years and 2.9% for >70 years. For men with 
CP, prevalence of osteoporosis was 3.5% for 18-30 years and 10.0% for >70 years.  
 Unadjusted prevalence of osteoporosis across age and sex strata for adults with CP that 
had private and public insurance is presented in Figure 2. Both groups with CP had higher 
prevalence of osteoporosis compared to adults without CP. Publicly insured women and men 
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with CP had higher prevalence of osteoporosis compared to privately insured women and men 
with CP for all age groups, except for the 18-30 year age group.  
 
Discussion 
 The chief finding of this study is that women and men with CP had higher prevalence of 
osteoporosis compared to women and men without CP. While the prevalence of osteoporosis was 
higher for publicly and privately insured adults with CP compared to adults without CP for each 
age group and for both sexes, the prevalence was more pronounced among individuals that had 
public insurance. These findings are important, because the updated 2018 evidence-based 
guidelines set forth by the U.S. Preventive Services Task Force(32) recommends screening for 
osteoporosis in all adults 65 years of age and older, but provides no recommendations for the 
growing adult CP population,(33,34) or other adult populations with pediatric-onset disabilities and 
resultant skeletal fragility. Study findings provide large, national-level data to support the need 
for: (1) earlier preventive and health management services for osteoporosis; (2) future research to 
investigate osteoporosis-related burdens specific to the adult population with CP; and (3) clinical 
studies to maximize musculoskeletal development throughout growth for children with CP to 
offset the early development of osteoporosis. 
 The prevalence of osteoporosis among women and men without CP from the current 
study is slightly lower or similar to that previously reported for adults 50 years of age and older 
from the National Health and Nutrition Examination Survey (NHANES) 2005-2010 data.(1) The 
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reason for our data showing slightly lower prevalence for some age groups is that we used 
insurance-based claims for a medical diagnosis of osteoporosis (criteria for diagnosis is not 
stated in claims data), whereas NHANES osteoporosis was identified through dual‐energy x‐ray 
absorptiometry (DXA), thus better detecting osteoporosis. It is not uncommon to under detect 
osteoporosis in the clinical setting, which is where administrative claims data are derived. 
Nevertheless, our sample of adults without CP included 8.7 million beneficiaries of private 
insurance in 2016; a sample that likely reflects the general employed population without severe 
medical conditions that require frequent healthcare utilization.   
 Data from the current study represent the largest known sample of claims data for adults 
with CP evaluated for osteoporosis prevalence. We found that prevalence of osteoporosis was 
higher among adults with CP than adults without CP, and the prevalence increased with age, 
except for men >70 years old with public insurance. The reason for the dip in osteoporosis 
prevalence among men >70 years old with public insurance may be due to a “survivor” effect. 
While both privately and publically insured adults with CP had lower prevalence at the oldest 
age group, the publically insured sample had even lower prevalence compared to the privately 
insured sample. Adults with CP have lower life expectancy,(35) and those covered by Medicare 
are presumably less healthy than those covered by Optum, which is due to a variety of factors 
including medical need and health plan-specific enrollment criteria. Therefore, the men with CP 
>70 years with public insurance may be abnormally healthy than what would be excepted for a 
CP diagnosis at that age. Nevertheless, our prevalence trends are concordant with previous 
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research in southeast Michigan showing that young adults (18-30 years) with CP have a 
musculoskeletal morbidity profile that is 10 times higher than young adults without CP,(29) with 
the trend of musculoskeletal morbidity becoming even more prevalent with older age.(23)  
 Our findings reflect long-term consequences of osteoporosis development by numerous 
factors that are inherent and a resulting sequela of a CP diagnosis. Premature birth,(36) poor 
oromotor function,(37) inadequate nutrition and calcium intake,(38) anticonvulsant use,(39) and non-
ambulation or immobility are commonly seen among individuals with CP, and are associated 
with low bone mineral density. Moreover, underdeveloped skeletal muscle(20,40) can lead to low 
mechanical loading during development,(41) exacerbating the inadequate accrual of bone mineral 
and structure.(21) With aging, factors contributing to osteoporosis only get worse. Individuals 
with CP experience reduced ambulatory ability(42) and develop other noncommunicable 
diseases(29) that contribute to early development of osteoporosis. Moreover, adults with CP are 
susceptible to complications associated with osteoporosis, including increased fracture risk, 
which is evident even after accounting for osteoporosis.(24)  
 Study findings highlight the need for osteoporosis surveillance for adults with CP. DXA 
is the gold-standard osteoporosis screening methodology and is currently only recommended for 
adults aged 65 and over, or younger women with certain risk factors (smoking, low body mass 
index, daily use of alcohol).(32) DXA has been shown to be a technically feasible test for 
individuals with CP, despite often relying on imaging of anatomical sites which are commonly 
sites of previous surgery in this population.(43) Earlier screening for skeletal health may allow for 
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earlier detection, preventive services, and rehabilitation efforts to prevent or attenuate the burden 
of osteoporosis, which is needed for adults with CP. Although, this notion is confounded by 
whether or not available osteoporosis-related treatment strategies actually work in reducing 
skeletal fragility for adults with CP. More research on this topic is warranted.     
 The major strength of this study was that we extracted data from both private (Optum) 
and public (Medicare) administrative claims. In doing so, we ascertained a very large nationwide 
sample of adults with CP, which not only increases external validity of study findings, but also 
provides robust prevalence estimates.  
However, this study also had several limitations. First, administrative claims data can be 
subject to inaccurate coding that could affect interpretation. Second, we used a single claim to 
define CP and osteoporosis. Previous validation studies have shown that two or more claims for 
a medical condition tends to improve accurate identification of that medical condition.(25,44) 
However, accurately identifying medical conditions depends on the number of years for the 
study period(26) and the medical condition examined.(25,26,45) A single claim-based definition for 
identifying a pediatric-onset disability and osteoporosis performs better compared to other 
medical conditions, with positive predictive values of ~80%(25) and up to 92%,(26) respectively. 
Third, we did not account for potential confounding factors, such as ethnicity, geographic region, 
or other socioeconomic status variables (e.g., education level). Although this was not the purpose 
of the present work, future research is needed to identify if socioeconomic status plays a role in 
the development or worsening of osteoporosis among adults with CP. Fourth, we were unable to 
This article is protected by copyright. All rights reserved.
16 
 
account for severity or type of CP as more than 70% of the cohort from Optum(46) and Medicare 
(unpublished observations) had “other” or “unspecified” CP. In light of this limitation, we 
stratified results by insurance coverage to serve as a proxy for severity of CP, as private 
insurance likely reflects the higher-functioning segment of the CP population and public 
insurance likely reflects the lower-functioning segment of the CP population. This speculation is 
based on differences in enrollment criteria between insurance types, medical needs of individuals 
with CP based on insurance coverage, and prevalent chronic diseases for adults with pediatric-
onset disabilities (higher among publicly vs. privately insured), including CP.(47) 
 In conclusion, adults with CP have higher prevalence of osteoporosis throughout the 
adult lifespan compared to adults without CP. Further, publicly insured women and men with CP 
showed higher prevalence of osteoporosis than privately insured women and men with CP. These 
data can inform future public health and clinical practice guidelines for screening and 
management of osteoporosis in patients with CP. Future research is needed to identify effective 
interventions to attenuate the burden of osteoporosis for individuals with CP.  
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Figure 1. Prevalence of osteoporosis among women (A) and men (B) with and without cerebral 
palsy (CP). 
Figure 2. Prevalence of osteoporosis among women (A) and men (B) with cerebral palsy (CP) 
by insurance coverage.  
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Table 1. Descriptive characteristics of study participants with and without cerebral palsy (CP).  
 Without CP With CP With CP 





 Point estimate Point estimate Point estimate 
Age, mean (SD) 55.2 (18.6) 49.8 (18.2)* 51.2 (15.6)*, ** 
  18-30 years, % 12.4 20.0 10.8 
  31-40 years, % 13.1 14.1 17.2 
  41-50 years, % 14.5 14.5 20.1 
  51-60 years, % 17.0 19.6 22.9 
  61-70 years, % 18.9 18.5 17.7 
  >70 years, % 24.1 13.3 11.3 
Sex, %      Female 55.3 49.2* 47.7* 
  Male 44.7 50.8* 52. 3* 
Osteoporosis, % 4.8 8.4* 14.3*, ** 
*Different compared to adults without CP, p<0.005. 
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